Oct 23 (Reuters) - Indian drugmaker Dr Reddy's Laboratories reported a better-than-expected quarterly profit on Friday, as domestic demand helped cushion the slowdown in its key US market.

By Rishika Sadam HYDERABAD, Oct 23 (Reuters) - Dr Reddy's Laboratories has expanded its portfolio of generic versions of ...

India's Global Capability Centres (GCCs) are projected to grow from approximately 2.3 million employees today to 3.3–3.7 million by 2031, adding 1–1.4 million net jobs and generating 150–170 million ...

Indian drugmaker Dr Reddy's Laboratories reported a better-than-expected quarterly profit on Friday, as domestic demand helped cushion the slowdown in its key US market. Consolidated net profit ​after ...

Dr Reddy's plans to relaunch semaglutide products in Canada by March. Relaunch will be executed through a partner based in ...

Odisha is betting big on chemicals, not just minerals. At India Chem in Mumbai, Chief Minister Mohan Charan Majhi said the ...

The Supreme Court has directed states to identify and demarcate all wetlands and water bodies, linking their protection to ...

India’s iPhone manufacturing drive highlights both the gains in local production and the ongoing debate over the real impact ...

Ashok Kumar's return to college offers an example of lifelong learning, showing that education need not be limited to the ...

Public health expert Dr Chandrakant Lahariya explains Qdenga’s efficacy, safety concerns, India’s indigenous dengue vaccine ...

Dr Reddy's Laboratories has expanded its ​portfolio of generic versions of Ozempic with two new brands, according to product ...